SynthesisJournal of cancer research and clinical oncology2024

Efficacy and safety of first-line therapy in patients with HER2-positive advanced breast cancer: a network meta-analysis of randomized controlled trials.

Junxiao Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.